GSA Capital Partners LLP acquired a new position in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 88,005 shares of the company’s stock, valued at approximately $648,000. A number of other [...]
88,005 Shares in Entrada Therapeutics, Inc. $TRDA Acquired by GSA Capital Partners LLP
